Drugs / LBVE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03467984 | May → Oct 2018 | pneumococcal infection | LG Chem | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LBVE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03467984 ↗ |
| Route | Intramuscular | “0.5mL intramuscular injection of LBVE” NCT03467984 ↗ |